NIH RFA-AG-24-001: 2024 Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Submit ticket request // Limit: 1 // Tickets Available: 1
Only one application per institution is allowed.
This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to establish, or renew, an Alzheimer's Disease Research Center (ADRC).
NIA-designated ADRCs serve as a national resource for research on the nature of Alzheimer’s disease (AD) and AD-related dementias (ADRD) and the development of more effective approaches to prevention, diagnosis, care, and therapy. They create shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with other NIH-funded programs and investigators.
Applications may request a budget of up to $2.925 million in direct costs per year.
The maximum project period is 5 years.
Areas of Interest
The objective of NIA's ADRC Program is to foster highly interactive, cutting-edge AD/ADRD research through core services that seek to accomplish the following:
- Create an environment that supports innovative multidisciplinary, inclusive research that has a significant impact on the field of dementia research and treatment;
- Foster interdisciplinary collaborations, especially in emerging areas of research, to catalyze new ideas and scientific approaches;
- Attract, educate and/or train, and retain a group of early stage investigators and investigators new to dementia research that is richly diverse in backgrounds, and academic and technical disciplines;
- Translate scientific discoveries from bench to bedside to community that improve public health and include validation and effectiveness measures;
- Provide rapid and broad sharing of analytic and research tools, as well as data, as appropriate and as consistent with achieving the goals of the program; and
- Enhance dementia-related research education opportunities for people living with dementia, their care partners, students, scientists, and clinicians.